E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/7/2015 in the Prospect News Structured Products Daily.

Credit Suisse to price trigger phoenix autocallables based on Pfizer

New York, July 7 – Credit Suisse AG, London Branch plans to price trigger phoenix autocallable optimization securities due July 16, 2020 linked to Pfizer Inc. shares, according to a 424B2 with the Securities and Exchange Commission.

If Pfizer stock closes at or above the coupon barrier level – 79% to 84% of the initial price – on any monthly observation date, the notes will pay a contingent coupon at an annualized rate of 7% for that month.

If the shares close at or above the initial price on any monthly observation date after one year, the notes will be called at par plus the contingent coupon.

If the notes are not called and Pfizer shares finish at or above the 79% to 84% trigger price, the payout at maturity will be par plus the contingent coupon.

Otherwise, investors will be fully exposed to any losses.

The notes (Cusip: 22548F406) will price on July 10 and settle on July 15.

UBS Financial Services Inc. will act as distributor.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.